Back to Search
Start Over
Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study.
- Source :
-
Ophthalmology [Ophthalmology] 2013 Sep; Vol. 120 (9), pp. 1944-5.e1. - Publication Year :
- 2013
- Subjects :
- Aged
Choroidal Neovascularization diagnosis
Choroidal Neovascularization etiology
Female
Follow-Up Studies
Humans
Intravitreal Injections
Male
Middle Aged
Myopia, Degenerative complications
Myopia, Degenerative diagnosis
Prospective Studies
Ranibizumab
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity physiology
Angiogenesis Inhibitors therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Choroidal Neovascularization drug therapy
Myopia, Degenerative drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1549-4713
- Volume :
- 120
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 24001532
- Full Text :
- https://doi.org/10.1016/j.ophtha.2013.06.010